Malignant News and Research

RSS

Researchers develop new tool to share clinico-genomic data

Researchers from Universidad Politécnica de Madrid have developed a new tool that provides standard and shared clinico-genomic data among European healthcare institutions.

20 Nov 2017

FAIMS technology holds potential to be effective screening tool for pancreatic cancer

In research published in the latest edition of the UEG Journal, Scientists in Finland demonstrated that there is variance in the volatile compounds found in the urine of pancreatic cancer patients to that of healthy controls.

17 Nov 2017

Study identifies molecular pathway critical to development of fibrosis

A study led by investigators at Massachusetts General Hospital and University Health Network in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis - scarring and excessive tissue deposition that result from abnormal healing responses and can compromise the function of vital organs.

15 Nov 2017

Study provides new insights into basis for responsiveness of testicular cancer to chemotherapy

Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?

14 Nov 2017

Novel AR glasses help doctors to locate lymph nodes during surgery

Malignant tumors often form metastases that spread to other parts of the body via the lymphatic system. High surgical skills are required to identify the precise location of the affected lymph nodes, enabling them to be completely removed.

14 Nov 2017

Scientists uncover mechanism that prevents tumor growth in melanoma

Natural Killer (NK) cells, lymphocytes of the innate immune system with strong cytotoxic activity, play a major role in the immune response against tumors.

8 Nov 2017

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Investigators from Brigham and Women's Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately.

31 Oct 2017

HPV vaccination and screening combination can decrease cancer risk by more than 90%

Every year there are around 400 new cases of cervical cancer and a total of approximately 800 cancers associated with HPV (human papilloma virus). Two measures could reverse this trend: the nonavalent HPV vaccination co-developed at MedUni Vienna's Department of Obstetrics and Gynecology under the supervision of Elmar Joura and HPV screening by means of smear tests as secondary prevention.

30 Oct 2017

Mechanical memory of cells could hold new clues to tumor invasion

In the body, cells move around to form organs during development; to heal wounds; and when they metastasize from cancerous tumors.

28 Oct 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

Newly identified microRNA impedes malignancy of tumor cells and metastasis

Cancer cells can reactivate a cellular process that is an essential part of embryonic development. This allows them to leave the primary tumor, penetrate the surrounding tissue and form metastases in peripheral organs.

27 Oct 2017

Pharmacist identifies protein linked to tumor growth in gallbladder cancer

Patients with gallbladder cancer often show few or no symptoms for long periods of time. As a result, the tumors are only detected at a late stage of the disease when treatment is often no longer possible.

25 Oct 2017

'Intelligent' nanoparticles could help treat cancer patients

Scientists from the University of Surrey have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells - but which then self-regulate and lose heat before they get hot enough to harm healthy tissue.

24 Oct 2017

New drug offers hope for treatment of aggressive T-PLL leukemia

Hitherto there has been no adequate treatment available for the rare and highly aggressive malignant blood disease T-PLL leukemia.

24 Oct 2017

Brazilian scientists examine how benzopyrene can cause cancer

Benzo[a]pyrene is a potent carcinogen and mutagen present in cigarette smoke, automotive exhaust, burnt wood fumes, barbecued and smoked meat etc.

23 Oct 2017

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Following a successful clinical trial involving Dana-Farber Cancer Institute and Brigham and Women's Hospital, the first chimeric antigen receptor (CAR) T-cell therapy for adult cancers was approved by the Food and Drug Administration today.

20 Oct 2017

Researchers reveal how certain nerves sustain prostate cancer growth

In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.

20 Oct 2017

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

The Photoelectric Therapy System is a compact and ergonomic superficial X-Ray therapy system operating in the 10 kV to 80 kV range intended for superficial radiotherapy and surface electronic brachytherapy treatment of primary malignant epithelial neoplasms of the skin and keloids.

From Xstrahl 19 Oct 2017

Synthetic compound targets enzyme that supports survival and dissemination of metastatic cells

Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body.

17 Oct 2017

Most ovarian cancers start in the fallopian tubes, study finds

Most - and possibly all - ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.